In this episode, we explore the complex pharmacological management of mixed mania, a challenging bipolar presentation affecting up to 40% of manic episodes. Why do traditional mood stabilizers like lithium fall short, and which second-generation antipsychotics emerge as first-line treatments for this dual-symptom condition?
Faculty: David Osser, M.D. Host: Richard Seeber, M.D.
Psychopharmacology and Psychiatry Updates